DOXORUBICIN MEDAC 2MG/ML INF SOL 1X25ML

What is the maximum co-payment for DOXORUBICIN MEDAC?

If the insurance company contributes, the maximum co-payment is 13,18 Kč. The maximum pharmacy price is 713,35 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but only during an outpatient procedure. When dispensed on prescription, the patient always pays the full price.

Does DOXORUBICIN MEDAC have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

700,17 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe DOXORUBICIN MEDAC?

clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
hematology and transfusion medicine, pediatric oncology and hematology

What is the composition of DOXORUBICIN MEDAC?

Doxorubicin-hydrochlorid (2 mg), doxorubicin (1,87 mg), chlorid sodný, kyselina chlorovodíková, voda pro injekci (1 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to DOXORUBICIN MEDAC?

The medicine belongs to ATC group L01DB01 – DOXORUBICIN. Medicines with the same active substance can be found here.

Who manufactures DOXORUBICIN MEDAC?

Medac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel (D)

Is the medicine in shortage?

The latest report from the manufacturer is from 24. 2. 2025. Production was terminated with effect from 1. 5. 2025. The manufacturer lists medicines with the following code as a potential substitute: